Abstract | OBJECTIVE: The purpose of this study was to assess whether sentinel lymph nodes (SLNs) that undergo targeted needle biopsy after identification by contrast-enhanced ultrasound (CEUS) using intradermally injected microbubbles results in more node-positive breast cancer patients being diagnosed preoperatively. Furthermore, we sought to determine whether the addition of CEUS to gray-scale sonography of the axilla reduces the number of patients having axillary lymph node (ALN) dissection as a second procedure. SUBJECTS AND METHODS: Intradermal microbubble injection was performed in 136 breast cancer patients who had no abnormal ALNs on routine gray-scale axillary sonography. When an enhancing ALN was visualized, percutaneous sonography-guided fine-needle aspiration cytology or core needle biopsy was performed. Depending on the biopsy results, patients underwent SLN biopsy or ALN dissection. If the putative SLN biopsy was positive or a biopsy tract was seen in the excised SLN, the procedure was defined as successful. RESULTS: SLNs were identified and biopsied in 126 of the 136 cases (93%). Seventeen patients had positive sonography-guided biopsy results (13%) and were treated with immediate ALN dissection. In seven patients, the biopsied node was the only positive node. The remaining 109 patients underwent SLN biopsy. In nine cases (8%), a positive lymph node was identified. Four of these false-negative cases had only micrometastases. CONCLUSION: SLNs can be identified and biopsied using CEUS to increase the accuracy of preoperative axillary staging. If the needle biopsy result is negative, conventional SLN biopsy is indicated.
|
Authors | Ali R Sever, Philippa Mills, Jennifer Weeks, Susan E Jones, David Fish, Peter A Jones, Willem Mali |
Journal | AJR. American journal of roentgenology
(AJR Am J Roentgenol)
Vol. 199
Issue 2
Pg. 465-70
(Aug 2012)
ISSN: 1546-3141 [Electronic] United States |
PMID | 22826414
(Publication Type: Journal Article)
|
Chemical References |
- Contrast Media
- Phospholipids
- contrast agent BR1
- Sulfur Hexafluoride
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Biopsy, Needle
- Breast Neoplasms
(diagnostic imaging, pathology)
- Breast Neoplasms, Male
(diagnostic imaging, pathology)
- Contrast Media
- Female
- Humans
- Lymph Node Excision
- Male
- Microbubbles
- Middle Aged
- Neoplasm Staging
- Phospholipids
- Prospective Studies
- Sentinel Lymph Node Biopsy
(methods)
- Sulfur Hexafluoride
- Ultrasonography, Interventional
- Ultrasonography, Mammary
|